Holding shares of AstraZeneca (AZN) provides investors with direct financial exposure to a world-leading multinational pharmaceutical and biotechnology enterprise. The company researches, develops, manufactures, and commercializes innovative prescription medicines focusing primarily on critical therapeutic areas, including oncology, rare diseases, cardiovascular, renal, metabolism, respiratory, and immunology conditions, generating global revenue streams across healthcare markets worldwide.